IM Cannabis Corp. Files May 2025 6-K Report

Ticker: IMCC · Form: 6-K · Filed: 2025-05-27T00:00:00.000Z

Sentiment: neutral

Topics: foreign-issuer, reporting

TL;DR

IM Cannabis Corp. filed its May 6-K, standard foreign issuer update.

AI Summary

IM Cannabis Corp. filed a Form 6-K on May 27, 2025, reporting for the month of May 2025. The company, incorporated in Israel with its principal executive offices at Kibbutz Glil Yam, Central District, Israel, is a foreign private issuer. It is required to file annual reports under Form 20-F.

Why It Matters

This filing provides routine updates for IM Cannabis Corp. as a foreign private issuer, informing investors about their ongoing reporting obligations.

Risk Assessment

Risk Level: low — This is a routine filing for a foreign private issuer and does not contain specific financial or operational news.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to provide information that the registrant makes or is required to make public in its home country, files or is required to file with a stock exchange, or distributes or is required to distribute to its security holders.

What is IM Cannabis Corp.'s filing status as per this report?

IM Cannabis Corp. is a foreign private issuer filing this Form 6-K.

Which form does IM Cannabis Corp. use for its annual reports?

IM Cannabis Corp. files its annual reports under cover of Form 20-F.

What is the principal executive office address for IM Cannabis Corp.?

The principal executive offices are located at Kibbutz Glil Yam, Central District, Israel, 4690500.

What is the filing date of this Form 6-K?

This Form 6-K was filed on May 27, 2025.

From the Filing

0001178913-25-001956.txt : 20250527 0001178913-25-001956.hdr.sgml : 20250527 20250527081141 ACCESSION NUMBER: 0001178913-25-001956 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20250527 FILED AS OF DATE: 20250527 DATE AS OF CHANGE: 20250527 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IM Cannabis Corp. CENTRAL INDEX KEY: 0001792030 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40065 FILM NUMBER: 25984359 BUSINESS ADDRESS: STREET 1: KIBBUTZ GLIL YAM CITY: CENTRAL DISTRICT STATE: L3 ZIP: 4690500 BUSINESS PHONE: 416-256-4202 MAIL ADDRESS: STREET 1: KIBBUTZ GLIL YAM CITY: CENTRAL DISTRICT STATE: L3 ZIP: 4690500 6-K 1 zk2533261.htm 6-K   UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934   For the month of May 2025 .   Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executive offices)   Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F ☒    Form 40-F ☐   Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____   Note : Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.   Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____   Note : Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant's "home country"), or under the rules of the home country exchange on which the registrant's securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant's security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.     SIGNATURE   Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.     IM CANNABIS CORP.   (Registrant)       Date:  May 27, 2025 By: /s/ Oren Shuster   Name: Oren Shuster   Title: Chief Executive Officer and Director   EXHIBIT INDEX   99.1 Report of Voting Results and News Release dated May 27, 2025   EX-99.1 2 exhibit_99-1.htm EXHIBIT 99.1 Exhibit 99.1 THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES IM Cannabis Provides Corporate Updates Toronto, Ontario and Glil Yam, Israel – May 27, 2025 – IM Cannabis Corp. (“ IM Cannabis ” or the “ Company ”) (NASDAQ: IMCC) (CSE: IMCC), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce the following corporate updates.   Meeting Results   Further to its press releases dated Aprill 11, 2025 (the “ April 11 Release ”) and May 7, 2025 (the “ May 7 Release ”), the Company is pleased to announce results of its annual general a

View on Read The Filing